Asset Details
Do you wish to reserve the book?
Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United Kingdom
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United Kingdom
Do you wish to request the book?
Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United Kingdom
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Evidence of the impact of CLN2 and CLN3 Batten disease on families in the United Kingdom
2025
Overview
Background
Neuronal Ceroid Lipofuscinoses (NCLs), also known as Batten disease, are a group of inherited neurodegenerative disorders that mostly arise in childhood. Each of the NCLs is a genetically distinct disease caused by variants in at least 13 different genes (
CLN1–CLN14
). NCLs are neurodegenerative, and symptoms can include a combination of childhood dementia, epileptic seizures, motor decline and vision loss, and eventually lead to premature death. There is currently no cure for any subtype of NCL, however, enzyme replacement therapy is available for CLN2 disease, and several treatment strategies are being explored for other NCL subtypes. Early diagnosis and initiation of supportive services (e.g. health, education, social services) are essential to preserve quality of life. Only a few studies have investigated family experiences with NCL, many of which are international in scope.
Methods
A mixed-method research study was conducted in the UK to understand family experiences in CLN2 and CLN3 disease. It involved an initial literature review, followed by in-depth qualitative interviews. Interview data were analysed using a thematic analysis. Thirteen families (
n
= 13) participated in the interviews. This represented 16 parents (11 mothers and 5 fathers) of 18 children (10 diagnosed with CLN3 disease and 8 diagnosed with CLN2 disease). Findings were analysed jointly across CLN2 and CLN3 disease.
Results
Six overarching themes emerged from the analysis: difficulty in recognising early symptoms; the shock of a diagnosis; the demands of caring for complex and ever-changing needs; a constant battle to access appropriate and timely support services; the extensive impact on the unaffected sibling; and the all-encompassing impact on the family.
Conclusions
This study contributes novel UK specific data on family experiences and unmet needs in CLN2 and CLN3 disease. More needs to be done to ensure NCLs are diagnosed early, and timely local support services are made available to protect quality of life for both the affected children and their families.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Adult
/ Child
/ Children
/ Dementia
/ Dipeptidyl-Peptidases and Tripeptidyl-Peptidases - genetics
/ Epilepsy
/ Female
/ Humans
/ Male
/ Medicine
/ Membrane Glycoproteins - genetics
/ Membrane Glycoproteins - metabolism
/ Molecular Chaperones - genetics
/ Neuronal ceroid lipofuscinoses
/ Neuronal ceroid lipofuscinosis
/ Neuronal Ceroid-Lipofuscinoses - epidemiology
/ Neuronal Ceroid-Lipofuscinoses - genetics
/ Parents
/ Seizures
/ Siblings
